Publications
Found 2 results
Filters: Author is Z.Q. Lin [Clear All Filters]
“Induction function of siRNA-mediated survivin gene silencing on nasopharyngeal carcinoma cell apoptosis”, vol. 14, pp. 2537-2545, 2015.
, “5-Aza-2’-deoxycytidine may influence the proliferation and apoptosis of cervical cancer cells via demethylation in a dose- and time-dependent manner”, vol. 12, pp. 312-318, 2013.
, Andreev DE, Dmitriev SE, Zinovkin R, Terenin IM, et al. (2012). The 5' untranslated region of Apaf-1 mRNA directs translation under apoptosis conditions via a 5' end-dependent scanning mechanism. FEBS Lett. 586: 4139-4143.
http://dx.doi.org/10.1016/j.febslet.2012.10.010
PMid:23085065
Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, et al. (2001). Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J. Natl. Cancer Inst. 93: 691-699.
http://dx.doi.org/10.1093/jnci/93.9.691
PMid:11333291
Christoph F, Kempkensteffen C, Weikert S, Kollermann J, et al. (2006). Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer. Br. J. Cancer 95: 1701-1707.
http://dx.doi.org/10.1038/sj.bjc.6603482
PMid:17133271 PMCid:2360762
Chu SH, Ma YB, Feng DF, Zhang H, et al. (2012). Effect of 5-Aza-2'-deoxycytidine on SLC22A18 in glioma U251 cells. Mol. Med. Report. 5: 138-141.
Dammann R, Takahashi T and Pfeifer GP (2001). The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas. Oncogene 20: 3563-3567.
http://dx.doi.org/10.1038/sj.onc.1204469
PMid:11429703
Dreijerink K, Braga E, Kuzmin I, Geil L, et al. (2001). The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 98: 7504-7509.
http://dx.doi.org/10.1073/pnas.131216298
PMid:11390984 PMCid:34698
Ferguson AT, Vertino PM, Spitzner JR, Baylin SB, et al. (1997). Role of estrogen receptor gene demethylation and DNA methyltransferase.DNA adduct formation in 5-aza-2'deoxycytidine-induced cytotoxicity in human breast cancer cells. J. Biol. Chem. 272: 32260-32266.
http://dx.doi.org/10.1074/jbc.272.51.32260
PMid:9405430
Hassler MR, Klisaroska A, Kollmann K, Steiner I, et al. (2012). Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine in anaplastic large cell lymphoma. Biochimie 94: 2297-2307.
http://dx.doi.org/10.1016/j.biochi.2012.05.029
PMid:22687603 PMCid:3480637
Kuzmin I, Gillespie JW, Protopopov A, Geil L, et al. (2002). The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells. Cancer Res. 62: 3498-3502.
PMid:12067994
Kuzmin I, Liu L, Dammann R, Geil L, et al. (2003). Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection. Cancer Res. 63: 1888-1893.
PMid:12702579
Kwong J, Lo KW, To KF, Teo PML, et al. (2002). Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin. Cancer Res. 8: 131-137.
PMid:11801549
Lee MG, Kim HY, Byun DS, Lee SJ, et al. (2001). Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. Cancer Res. 61: 6688-6692.
PMid:11559536
Liu L, Yoon JH, Dammann R and Pfeifer GP (2002). Frequent hypermethylation of the RASSF1A gene in prostate cancer. Oncogene 21: 6835-6840.
http://dx.doi.org/10.1038/sj.onc.1205814
PMid:12360410
Melzer IM, Fernandez SB, Bosser S, Lohrig K, et al. (2012). The Apaf-1-binding protein Aven is cleaved by Cathepsin D to unleash its anti-apoptotic potential. Cell Death. Differ. 19: 1435-1445.
http://dx.doi.org/10.1038/cdd.2012.17
PMid:22388353
Menschikowski M, Platzbecker U, Hagelgans A, Vogel M, et al. (2012). Aberrant methylation of the M-type phospholipase A2 receptor gene in leukemic cells. BMC Cancer 12: 576.
http://dx.doi.org/10.1186/1471-2407-12-576
PMid:23217014 PMCid:3561142
Montenegro MF, Saez-Ayala M, Pinero-Madrona A, Cabezas-Herrera J, et al. (2012). Reactivation of the Tumour Suppressor RASSF1A in Breast Cancer by Simultaneous Targeting of DNA and E2F1 Methylation. PLoS One 7: e52231.
http://dx.doi.org/10.1371/journal.pone.0052231
PMid:23251702 PMCid:3522638
Niimi S, Arakawa-Takeuchi S, Uranbileg B, Park JH, et al. (2012). Cdc6 protein obstructs apoptosome assembly and consequent cell death by forming stable complexes with activated Apaf-1 molecules. J. Biol. Chem. 287: 18573-18583.
http://dx.doi.org/10.1074/jbc.M112.347690
PMid:22493447
Ozdemir F, Altinisik J, Karateke A, Coksuer H, et al. (2012). Methylation of tumor suppressor genes in ovarian cancer. Exp. Ther. Med. 4: 1092-1096.
PMid:23226780 PMCid:3494110
Sankaranarayanan R and Ferlay J (2006). Worldwide burden of gynaecological cancer: the size of the problem. Best. Pract. Res. Clin. Obstet. Gynaecol. 20: 207-225.
http://dx.doi.org/10.1016/j.bpobgyn.2005.10.007
PMid:16359925
Vos MD, Ellis CA, Bell A, Birrer MJ, et al. (2000). Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J. Biol. Chem. 275: 35669-35672.
http://dx.doi.org/10.1074/jbc.C000463200
PMid:10998413
Wu Y, Meng L, Wang H, Xu Q, et al. (2006). Regulation of DNA methylation on the expression of the FHIT gene contributes to cervical carcinoma cell tumorigenesis. Oncol. Rep. 16: 625-629.
PMid:16865265